Sanuwave Health ROE 2010-2025 | SNWV
Current and historical return on equity (ROE) values for Sanuwave Health (SNWV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Sanuwave Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.03B | $-0.02B | 101.54% |
| 2024-12-31 | $-0.03B | $-0.01B | 79.50% |
| 2024-09-30 | $0.00B | $-0.06B | 2.09% |
| 2024-06-30 | $0.00B | $-0.04B | 8.12% |
| 2024-03-31 | $-0.02B | $-0.05B | 33.03% |
| 2023-12-31 | $-0.03B | $-0.04B | 46.43% |
| 2023-09-30 | $-0.05B | $-0.07B | 90.09% |
| 2023-06-30 | $-0.03B | $-0.06B | 57.14% |
| 2023-03-31 | $-0.02B | $-0.05B | 44.44% |
| 2022-12-31 | $-0.01B | $-0.04B | 27.59% |
| 2022-09-30 | $-0.01B | $-0.03B | 36.36% |
| 2022-06-30 | $-0.02B | $-0.03B | 45.71% |
| 2022-03-31 | $-0.03B | $-0.04B | 82.44% |
| 2021-12-31 | $-0.03B | $-0.04B | 97.30% |
| 2021-09-30 | $-0.03B | $-0.03B | 139.53% |
| 2021-06-30 | $-0.04B | $-0.03B | 240.00% |
| 2021-03-31 | $-0.03B | $-0.02B | 247.27% |
| 2020-12-31 | $-0.03B | $-0.01B | 250.98% |
| 2020-09-30 | $-0.02B | $-0.01B | 195.74% |
| 2020-06-30 | $-0.01B | $-0.02B | 101.96% |
| 2020-03-31 | $-0.01B | $-0.01B | 92.31% |
| 2019-12-31 | $-0.01B | $-0.01B | 80.00% |
| 2019-09-30 | $-0.01B | $-0.01B | 66.67% |
| 2019-06-30 | $-0.01B | $-0.02B | 53.33% |
| 2019-03-31 | $-0.01B | $-0.02B | 54.24% |
| 2018-12-31 | $-0.01B | $-0.02B | 84.21% |
| 2018-09-30 | $-0.01B | $-0.01B | 100.00% |
| 2018-06-30 | $-0.01B | $-0.02B | 108.33% |
| 2018-03-31 | $-0.01B | $-0.01B | 107.32% |
| 2017-12-31 | $-0.01B | $-0.01B | 58.82% |
| 2017-09-30 | $0.00B | $-0.01B | 51.61% |
| 2017-06-30 | $0.00B | $-0.01B | 57.14% |
| 2017-03-31 | $0.00B | $-0.01B | 61.54% |
| 2016-12-31 | $-0.01B | $-0.01B | 100.00% |
| 2016-09-30 | $-0.01B | $-0.01B | 86.96% |
| 2016-06-30 | $-0.01B | $-0.01B | 90.91% |
| 2016-03-31 | $-0.01B | $-0.01B | 120.00% |
| 2015-12-31 | $-0.01B | $-0.01B | 111.11% |
| 2015-09-30 | $0.00B | $-0.01B | 114.29% |
| 2015-06-30 | $0.00B | $0.00B | 177.78% |
| 2015-03-31 | $0.00B | $0.00B | 400.00% |
| 2014-12-31 | $-0.01B | $0.00B | -2400.00% |
| 2014-09-30 | $-0.01B | $0.00B | 933.33% |
| 2014-06-30 | $-0.01B | $0.00B | 444.44% |
| 2014-03-31 | $-0.01B | $0.00B | 163.64% |
| 2013-12-31 | $-0.01B | $-0.01B | 125.71% |
| 2013-09-30 | $-0.01B | $-0.01B | 133.33% |
| 2013-06-30 | $-0.01B | $-0.01B | 100.00% |
| 2013-03-31 | $-0.01B | $-0.01B | 128.57% |
| 2012-12-31 | $-0.01B | $-0.01B | 120.00% |
| 2012-09-30 | $-0.01B | $-0.01B | 160.00% |
| 2012-06-30 | $-0.01B | $0.00B | 311.11% |
| 2012-03-31 | $-0.01B | $0.00B | 1333.33% |
| 2011-12-31 | $-0.01B | $0.00B | 444.44% |
| 2011-09-30 | $-0.02B | $0.00B | 333.33% |
| 2011-06-30 | $-0.02B | $0.00B | 206.45% |
| 2011-03-31 | $-0.02B | $-0.01B | 136.36% |
| 2010-12-31 | $-0.02B | $-0.01B | 148.84% |
| 2010-09-30 | $-0.01B | $-0.01B | 126.32% |
| 2010-06-30 | $-0.01B | $-0.01B | 165.52% |
| 2010-03-31 | $-0.01B | $-0.01B | 177.78% |
| 2009-12-31 | $-0.01B | $-0.01B | 280.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.281B | $0.033B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $239.054B | 28.75 |
| Boston Scientific (BSX) | United States | $154.291B | 38.63 |
| Stryker (SYK) | United States | $149.710B | 31.30 |
| EssilorLuxottica (ESLOY) | France | $128.407B | 0.00 |
| Medtronic (MDT) | Ireland | $110.260B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.622B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.216B | 26.92 |
| ResMed (RMD) | United States | $37.817B | 28.40 |
| Agilent Technologies (A) | United States | $33.696B | 21.97 |
| GE HealthCare Technologies (GEHC) | United States | $33.311B | 15.81 |
| Terumo (TRUMY) | Japan | $27.198B | 35.33 |
| Koninklijke Philips (PHG) | Netherlands | $23.033B | 16.16 |
| Insulet (PODD) | United States | $21.551B | 84.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.358B | 11.79 |
| Baxter (BAX) | United States | $15.708B | 11.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.095B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.558B | 22.82 |
| Lantheus Holdings (LNTH) | United States | $5.573B | 14.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.039B | 18.04 |
| Perrigo (PRGO) | Ireland | $3.660B | 9.28 |
| Haemonetics (HAE) | United States | $3.526B | 16.06 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.280B | 27.25 |
| ICU Medical (ICUI) | United States | $3.251B | 23.97 |
| GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
| LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
| QuidelOrtho (QDEL) | United States | $1.901B | 13.07 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| Acuren (TIC) | United States | $1.263B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.216B | 12.34 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Neogen (NEOG) | United States | $1.057B | 13.53 |
| BioLife Solutions (BLFS) | United States | $1.015B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.003B | 12.82 |
| Kestra Medical Technologies (KMTS) | United States | $0.908B | 0.00 |
| InMode (INMD) | Israel | $0.898B | 9.05 |
| CeriBell (CBLL) | United States | $0.698B | 0.00 |
| Owens & Minor (OMI) | United States | $0.607B | 5.04 |
| Evolus (EOLS) | United States | $0.587B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.578B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Valneva SE (VALN) | France | $0.468B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.459B | 0.00 |
| Surmodics (SRDX) | United States | $0.413B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.396B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.335B | 12.32 |
| SNDL (SNDL) | Canada | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.250B | 11.34 |
| Sanara MedTech (SMTI) | United States | $0.249B | 0.00 |
| Quanterix (QTRX) | United States | $0.241B | 0.00 |
| Brainsway (BWAY) | Israel | $0.233B | 61.65 |
| Biote (BTMD) | United States | $0.227B | 6.37 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.220B | 65.33 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Omeros (OMER) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.197B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.71 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.144B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.32 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.074B | 0.00 |
| Apyx Medical (APYX) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.063B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 59.98 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.25 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |